Year |
Citation |
Score |
2022 |
Schiff JP, Mintz R, Cohen AC, Huang Y, Thaker P, Massad LS, Powell M, Mutch D, Schwarz JK, Markovina ST, Grigsby PW. Overall survival in patients with FIGO stage IVA cervical cancer. Gynecologic Oncology. PMID 35691754 DOI: 10.1016/j.ygyno.2022.05.022 |
0.316 |
|
2022 |
Mckinnish TR, Greenwade MM, Wilkinson-Ryan I, Schwarz JK, Powell MA, Mutch DG, Massad LS, Grigsby PW, Siegel BA, Thaker PH. Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography. Gynecologic Oncology. PMID 35537885 DOI: 10.1016/j.ygyno.2022.04.018 |
0.315 |
|
2021 |
Zhang J, Rashmi R, Inkman M, Jayachandran K, Ruiz F, Waters MR, Grigsby PW, Markovina S, Schwarz JK. Integrating imaging and RNA-seq improves outcome prediction in cervical cancer. The Journal of Clinical Investigation. 131. PMID 33645544 DOI: 10.1172/JCI139232 |
0.303 |
|
2020 |
Duska LR, Scalici JM, Temkin SM, Schwarz JK, Crane EK, Moxley KM, Hamilton CA, Wethington SL, Petroni GR, Varhegyi NE, Clift SH, Bullock TNJ, Showalter TN. Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. PMID 32910478 DOI: 10.1002/Cncr.33136 |
0.327 |
|
2020 |
Inkman MJ, Jayachandran K, Ellis TM, Ruiz F, McLellan MD, Miller CA, Wu Y, Ojesina AI, Schwarz JK, Zhang J. HPV-EM: an accurate HPV detection and genotyping EM algorithm. Scientific Reports. 10: 14340. PMID 32868873 DOI: 10.1038/S41598-020-71300-7 |
0.302 |
|
2020 |
Srivastava AJ, Contreras JA, Davis M, Markovina ST, Schwarz JK, Grigsby PW. Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma. Cancer. PMID 32639597 DOI: 10.1002/Cncr.33040 |
0.379 |
|
2020 |
Contreras J, Srivastava A, Chundury A, Schwarz JK, Markovina S, Thaker PH, Massad LS, Mutch DG, Powell MA, Grigsby PW, Lin AJ. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 32527770 DOI: 10.1136/Ijgc-2020-001412 |
0.389 |
|
2020 |
Rudra S, Fuser D, DeWees TA, Wan L, Gang M, Hui CY, Rao YJ, Siegel BA, Dehdashti F, Mutch DG, Powell MA, Schwarz JK, Grigsby PW, Chen DL, Markovina S. Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 32487684 DOI: 10.1136/Ijgc-2020-001363 |
0.331 |
|
2020 |
Grigsby PW, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt C, Hagemann A, Fuh K, Kuroki L, Schwarz JK, Markovina S, Lin AJ, Dehdashti F, Siegel BA. FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival. Gynecologic Oncology. PMID 32248993 DOI: 10.1016/J.Ygyno.2020.03.027 |
0.365 |
|
2020 |
Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, ... ... Schwarz JK, et al. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 37: 289-307.e9. PMID 32183949 DOI: 10.1016/J.Ccell.2020.02.008 |
0.333 |
|
2019 |
Cosper PF, McNair C, González I, Wong N, Knudsen KE, Chen JJ, Markovina S, Schwarz JK, Grigsby PW, Wang X. Decreased Local Immune Response and Retained HPV Gene Expression during Chemoradiotherapy are Associated with Treatment Resistance and Death from Cervical Cancer. International Journal of Cancer. PMID 31732968 DOI: 10.1002/Ijc.32793 |
0.373 |
|
2019 |
Lin AJ, Wright JD, Dehdashti F, Siegel BA, Markovina S, Schwarz J, Thaker PH, Mutch DG, Powell MA, Grigsby PW. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 31473660 DOI: 10.1136/Ijgc-2019-000528 |
0.403 |
|
2019 |
Wisdom AJ, Hong CS, Lin AJ, Xiang Y, Cooper DE, Zhang J, Xu ES, Kuo HC, Mowery YM, Carpenter DJ, Kadakia KT, Himes JE, Luo L, Ma Y, Williams N, ... ... Schwarz JK, et al. Neutrophils promote tumor resistance to radiation therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 31462499 DOI: 10.1073/Pnas.1901562116 |
0.432 |
|
2019 |
Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, et al. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. 11. PMID 31270275 DOI: 10.1126/Scitranslmed.Aau9240 |
0.322 |
|
2019 |
Lin AJ, Samson P, Zoberi J, Garcia-Ramirez J, Williamson JF, Markovina S, Schwarz J, Grigsby PW. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy. Brachytherapy. PMID 30971370 DOI: 10.1016/J.Brachy.2018.11.008 |
0.386 |
|
2019 |
Lin AJ, Ma S, Markovina S, Schwarz J, Mutch DG, Powell MA, Grigsby PW. Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation. Gynecologic Oncology. PMID 30905434 DOI: 10.1016/J.Ygyno.2019.03.104 |
0.405 |
|
2019 |
Lin A, Ma S, Dehdashti F, Markovina S, Schwarz J, Siegel B, Powell M, Grigsby P. Detection of distant metastatic disease by positron emission tomography with F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 30739082 DOI: 10.1136/Ijgc-2018-000108 |
0.381 |
|
2019 |
Floberg JM, Schwarz JK. Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response. Seminars in Radiation Oncology. 29: 33-41. PMID 30573182 DOI: 10.1016/J.Semradonc.2018.10.007 |
0.345 |
|
2019 |
Hassanzadeh C, Srivastava A, Markovina S, Schwarz J, Grigsby P. Prognostic Significance of pl6 in Patients with Cervical Cancer Receiving Definitive Chemoradiation International Journal of Radiation Oncology*Biology*Physics. 103: E33. DOI: 10.1016/S0360-3016(19)30480-8 |
0.424 |
|
2019 |
Srivastava A, Barnes J, Markovina S, Schwarz J, Grigsby P. The Impact of the Closure of Women’s Health Clinics on Cervical Cancer in the United States International Journal of Radiation Oncology*Biology*Physics. 105: S98. DOI: 10.1016/J.Ijrobp.2019.06.581 |
0.325 |
|
2018 |
Lin AJ, Hassanzadeh C, Markovina S, Schwarz J, Grigsby P. Brachytherapy and survival in small cell cancer of the cervix and uterus. Brachytherapy. PMID 30563743 DOI: 10.1016/J.Brachy.2018.11.006 |
0.346 |
|
2018 |
Lin AJ, Samson P, DeWees T, Henke L, Baranski T, Schwarz J, Pfeifer J, Grigsby P, Markovina S. A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer. Cancer Medicine. PMID 30552739 DOI: 10.1002/Cam4.1857 |
0.335 |
|
2018 |
Lin AJ, Kidd E, Dehdashti F, Siegel BA, Mutic S, Thaker PH, Massad LS, Powell MA, Mutch DG, Markovina S, Schwarz J, Grigsby PW. IMRT and image-guided adapted brachytherapy for cervix cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30445171 DOI: 10.1016/J.Ijrobp.2018.11.012 |
0.343 |
|
2018 |
Floberg JM, Fowler KJ, Fuser D, DeWees TA, Dehdashti F, Siegel BA, Wahl RL, Schwarz JK, Grigsby PW. Spatial relationship of 2-deoxy-2-[F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer. Ejnmmi Research. 8: 52. PMID 29904822 DOI: 10.1186/S13550-018-0403-7 |
0.345 |
|
2018 |
Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, et al. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29885996 DOI: 10.1016/J.Ijrobp.2018.04.049 |
0.301 |
|
2018 |
Grigsby P, Elhammali A, Ruiz F, Markovina S, McLellan MD, Miller CA, Chundury A, Ta NL, Rashmi R, Pfeifer JD, Fulton RS, DeWees T, Schwarz JK. Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer. Oncotarget. 9: 4061-4073. PMID 29423104 DOI: 10.18632/Oncotarget.23664 |
0.319 |
|
2018 |
Rashmi R, Huang X, Floberg JM, Elhammali A, McCormick ML, Patti GJ, Spitz DR, Schwarz JK. Radio-resistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism. Cancer Research. PMID 29339540 DOI: 10.1158/0008-5472.Can-17-2367 |
0.362 |
|
2018 |
Schwarz JK. Abstract SY24-02: Improving radio-sensitivity in cervical cancer by targeting tumor metabolism Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Sy24-02 |
0.42 |
|
2018 |
Muhammad N, Rashmi R, Ruiz F, Zahner MC, Schwarz JK. Abstract 5463: Free fatty acids augment radiation-induced cytotoxicity in cervical cancer cells via mTOR/Akt//PPARg/p53-mediated pathway Cancer Research. 78: 5463-5463. DOI: 10.1158/1538-7445.Am2018-5463 |
0.388 |
|
2018 |
Srivastava A, Contreras J, Davis M, Markovina S, Schwarz J, Grigsby P. Early Post-Therapy Clearance of Human Papillomavirus and Treatment Response in Cervical Carcinoma International Journal of Radiation Oncology*Biology*Physics. 102: S219-S220. DOI: 10.1016/J.Ijrobp.2018.07.141 |
0.328 |
|
2018 |
Floberg J, Zhang J, DeWees T, Markovina S, Grigsby P, Schwarz J. Pre-Treatment [F-18]FDG-PET SUVmax as a Prognostic and Radiogenomic Marker in Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 102: S82-S83. DOI: 10.1016/J.Ijrobp.2018.06.218 |
0.374 |
|
2018 |
Chundury A, Contreras J, Srivastava A, Schwarz J, Thaker P, Kuroki L, Mutch DG, Powell MA, Grigsby P. (P23) Toxicity of Post-Operative Intensity Modulated Radiation Therapy in Patients With Endometrial Cancer International Journal of Radiation Oncology*Biology*Physics. 101: E30. DOI: 10.1016/J.Ijrobp.2018.02.111 |
0.371 |
|
2017 |
Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, et al. The Future of Radiobiology. Journal of the National Cancer Institute. PMID 29126306 DOI: 10.1093/Jnci/Djx231 |
0.324 |
|
2017 |
Markovina S, Wang S, Henke LE, Luke CJ, Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, Mutch D, Wang X, Powell MA, Siegel BA, Dehdashti F, et al. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. British Journal of Cancer. PMID 29112685 DOI: 10.1038/Bjc.2017.390 |
0.408 |
|
2017 |
Rao YJ, Chundury A, Schwarz JK, Hassanzadeh C, DeWees T, Mullen D, Powell MA, Mutch DG, Grigsby PW. Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes. Advances in Radiation Oncology. 2: 148-158. PMID 28740926 DOI: 10.1016/J.Adro.2017.02.006 |
0.364 |
|
2017 |
Rao YJ, Chin RI, Hui C, Mutch DG, Powell MA, Schwarz JK, Grigsby PW, Markovina S. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. Gynecologic Oncology. PMID 28662775 DOI: 10.1016/J.Ygyno.2017.06.022 |
0.43 |
|
2017 |
Rao YJ, Hui C, Chundury A, Schwarz JK, DeWees T, Powell MA, Mutch DG, Grigsby PW. Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysis. Brachytherapy. PMID 28533162 DOI: 10.1016/J.Brachy.2017.03.012 |
0.389 |
|
2017 |
Ioffe YJ, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW. Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment. Gynecologic and Obstetric Investigation. PMID 28399524 DOI: 10.1159/000458706 |
0.385 |
|
2017 |
Rao YJ, Zoberi JE, Kadbi M, Grigsby PW, Cammin J, Mackey SL, Garcia-Ramirez J, Goddu SM, Schwarz JK, Gach HM. Metal artifact reduction in MRI-based cervical cancer intracavitary brachytherapy. Physics in Medicine and Biology. 62: 3011-3024. PMID 28306556 DOI: 10.1088/1361-6560/62/8/3011 |
0.303 |
|
2017 |
Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, ... ... Schwarz J, et al. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). International Journal of Radiation Oncology, Biology, Physics. 97: 536-545. PMID 28126303 DOI: 10.1016/J.Ijrobp.2016.11.027 |
0.399 |
|
2017 |
Rao YJ, Hassanzadeh C, Chundury A, Hui C, Siegel BA, Dehdashti F, DeWees T, Mullen D, Powell MA, Mutch DG, Schwarz JK, Grigsby PW. Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28063696 DOI: 10.1016/J.Radonc.2016.12.019 |
0.378 |
|
2017 |
Ruiz FJ, Schwarz JK. Abstract 4751: Correlating the genomic and transcriptomic profiles of pre-treatment cervical tumor biopsies with patient recurrence after definitive chemoradiation Cancer Research. 77: 4751-4751. DOI: 10.1158/1538-7445.Am2017-4751 |
0.321 |
|
2017 |
Cosper P, Zhang X, Schwarz J, Grigsby P, Wang X. Maintenance of HPV Gene Expression and Decreased Local Immune Response During Chemoradiation are Associated With Death From Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S205. DOI: 10.1016/J.Ijrobp.2017.06.508 |
0.335 |
|
2017 |
Markovina S, Wang S, Cosper P, Luke C, Pak S, Liu W, Chen S, Schwarz J, Wang X, Silverman G, Grigsby P. Squamous Cell Carcinoma Antigen Mediates Radiation Resistance in Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S146-S147. DOI: 10.1016/J.Ijrobp.2017.06.339 |
0.381 |
|
2017 |
Harkenrider M, Adams W, Nieto K, Aref I, Bergman D, Chundury A, Elshaikh M, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan A, et al. Multi-institutional Analysis of Vaginal Brachytherapy Without External Beam Radiation Therapy for Stage II Endometrial Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 99: S112. DOI: 10.1016/J.Ijrobp.2017.06.265 |
0.364 |
|
2017 |
Rao Y, Zoberi J, Kadbi M, Cammin J, Mackey S, Garcia-Ramirez J, Goddu S, Markovina S, Schwarz J, Grigsby P, Gach H. Prospective Study Evaluating Metal Artifact Reduction in MRI-Based Cervical Cancer Intracavitary Brachytherapy International Journal of Radiation Oncology*Biology*Physics. 99: S92. DOI: 10.1016/J.Ijrobp.2017.06.222 |
0.349 |
|
2017 |
Floberg J, Rashmi R, Zhou D, Chu W, Bandara N, Rogers B, Shoghi K, Schwarz J. Characterizing Oxidative Stress in Cervical Cancer Cell Lines Using a Novel Positron Emission Tomography Probe [F-18]Dihydroethidium: Implications for Radiation and Redox Directed Therapies International Journal of Radiation Oncology*Biology*Physics. 99: E590. DOI: 10.1016/J.Ijrobp.2017.06.2021 |
0.369 |
|
2017 |
Chin R, Rao Y, Hui C, Mutch D, Powell M, Schwarz J, Grigsby P. Improved Survival with Definitive Chemoradiation Compared to Definitive Radiation Alone in Squamous Cell Carcinoma of the Vulva International Journal of Radiation Oncology*Biology*Physics. 99: E285. DOI: 10.1016/J.Ijrobp.2017.06.1283 |
0.322 |
|
2017 |
Hassanzadeh C, Rao Y, Schwarz J, DeWees T, Siegel B, Dehdashti F, Grigsby P. Correlation and Prognostic Significance of Pre-treatment 18F-FDG and 64Cu-ATSM PET/CT for Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S26. DOI: 10.1016/J.Ijrobp.2017.06.073 |
0.357 |
|
2017 |
Contreras JA, Chundury A, Srivastava A, Schwarz J, Thaker P, Lindsay K, Mutch D, Powell M, Grigsby P. (P044) Toxicity of Post-Operative Intensity Modulated Radiation Therapy in Patients With Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 98: E27. DOI: 10.1016/J.Ijrobp.2017.02.139 |
0.394 |
|
2017 |
Rao Y, Hui C, Chundury A, Powell M, Mutch D, Schwarz J, Grigsby P. Primary Tumor-Directed Brachytherapy Is Associated with Improved Survival for Patients with Metastatic Cervical or Uterine Carcinoma Brachytherapy. 16: S34. DOI: 10.1016/J.Brachy.2017.04.043 |
0.344 |
|
2016 |
Jones E, Beriwal S, Beyer D, Chino J, Jhingran A, Lee L, Michalski J, Mundt AJ, Patton C, Petersen I, Portelance L, Schwarz JK, McCloskey S. An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary. Advances in Radiation Oncology. 1: 26-34. PMID 28799571 DOI: 10.1016/J.Adro.2015.10.001 |
0.358 |
|
2016 |
Mell LK, Sirak I, Wei L, Tarnawski RR, Mahantshetty UM, Yashar CM, McHale MT, Wright ME, Pritz J, Straube W, Xu R, Kasaova L, Michalski JM, Bosch WR, Followill DS, ... Schwarz JK, et al. Phase 2 Multicenter Clinical Trial of Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S13. PMID 27675598 DOI: 10.1016/J.Ijrobp.2016.06.046 |
0.311 |
|
2016 |
Rao YJ, Schwarz JK, DeWees TA, Mullen D, Powell M, Mutch DG, Grigsby PW. Intensity Modulated Radiation Therapy for Vulvar Cancer: Predictors of Local Control and Survival. International Journal of Radiation Oncology, Biology, Physics. 96: E309. PMID 27674337 DOI: 10.1016/J.Ijrobp.2016.06.1403 |
0.369 |
|
2016 |
Chin RI, Tran L, Thomas MA, Siegel B, Dehdashti F, Kidd EA, Schwarz JK, Grigsby PW. Changes in Cervical Cancer FDG Uptake Heterogeneity After Chemoradiation: Association With Tumor Recurrence and Survival. International Journal of Radiation Oncology, Biology, Physics. 96: E296-E297. PMID 27674300 DOI: 10.1016/J.Ijrobp.2016.06.1370 |
0.407 |
|
2016 |
Ordikhani F, Erdem Arslan M, Marcelo R, Sahin I, Grigsby P, Schwarz JK, Azab AK. Drug Delivery Approaches for the Treatment of Cervical Cancer. Pharmaceutics. 8. PMID 27447664 DOI: 10.3390/Pharmaceutics8030023 |
0.344 |
|
2016 |
Zoberi JE, Garcia-Ramirez J, Hu Y, Sun B, Bertelsman CG, Dyk P, Schwarz JK, Grigsby PW. Clinical implementation of multisequence MRI-based adaptive intracavitary brachytherapy for cervix cancer. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 17: 5736. PMID 26894342 DOI: 10.1120/Jacmp.V17I1.5736 |
0.337 |
|
2016 |
Chundury A, Apicelli A, DeWees T, Powell M, Mutch D, Thaker P, Robinson C, Grigsby PW, Schwarz JK. Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy. Gynecologic Oncology. PMID 26876923 DOI: 10.1016/J.Ygyno.2016.02.005 |
0.394 |
|
2015 |
Acharya S, Esthappan J, Badiyan S, DeWees TA, Tanderup K, Schwarz JK, Grigsby PW. Medically inoperable endometrial cancer in patients with a high body mass index (BMI): Patterns of failure after 3-D image-based high dose rate (HDR) brachytherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26743834 DOI: 10.1016/J.Radonc.2015.12.019 |
0.365 |
|
2015 |
Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W, Thomadsen B, Yashar C, Viswanathan A. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy. PMID 26186975 DOI: 10.1016/J.Brachy.2015.06.002 |
0.362 |
|
2015 |
Bagade S, Fowler KJ, Schwarz JK, Grigsby PW, Dehdashti F. PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer. Seminars in Nuclear Medicine. 45: 293-303. PMID 26050657 DOI: 10.1053/J.Semnuclmed.2015.03.005 |
0.34 |
|
2015 |
Sun B, Yang D, Esthappan J, Garcia-Ramirez J, Price S, Mutic S, Schwarz JK, Grigsby PW, Tanderup K. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer. Brachytherapy. 14: 481-9. PMID 25958039 DOI: 10.1016/J.Brachy.2015.04.003 |
0.307 |
|
2015 |
Paydar I, DeWees T, Powell M, Mutch DG, Grigsby PW, Schwarz JK. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control? Brachytherapy. 14: 427-32. PMID 25911995 DOI: 10.1016/J.Brachy.2015.02.196 |
0.365 |
|
2015 |
Dyk PT, Richardson S, Badiyan SN, Schwarz JK, Esthappan J, Garcia-Ramirez JL, Grigsby PW. Outpatient-based high-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy. 14: 231-7. PMID 25556865 DOI: 10.1016/J.Brachy.2014.11.017 |
0.386 |
|
2015 |
Williams SL, Wilkinson-Ryan I, Lederhandler S, Al-Hammadi N, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Grigsby PW, Schwarz JK. Outcomes for partial metabolic response on posttherapy positron emission tomography for cervical cancer: Role of surgical intervention Gynecologic Oncology. 137: 69-70. DOI: 10.1016/J.Ygyno.2015.01.166 |
0.355 |
|
2014 |
Liu W, Gao G, Hu X, Wang Y, Schwarz JK, Chen JJ, Grigsby PW, Wang X. Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget. 5: 11620-30. PMID 25344913 DOI: 10.18632/Oncotarget.2599 |
0.342 |
|
2014 |
Dyk P, Jiang N, Sun B, DeWees TA, Fowler KJ, Narra V, Garcia-Ramirez JL, Schwarz JK, Grigsby PW. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 90: 794-801. PMID 25245584 DOI: 10.1016/J.Ijrobp.2014.07.039 |
0.392 |
|
2014 |
Wilkinson-Ryan I, Binder PS, Pourabolghasem S, Al-Hammadi N, Fuh K, Hagemann A, Thaker P, Schwarz J, Grigsby P, Mutch D, Powell M. Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer. Gynecologic Oncology. 134: 24-8. PMID 24823648 DOI: 10.1016/J.Ygyno.2014.05.002 |
0.385 |
|
2014 |
Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Rader J, Grigsby PW, Schwarz JK. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. Plos One. 9: e92948. PMID 24705275 DOI: 10.1371/Journal.Pone.0092948 |
0.344 |
|
2014 |
Ioffe YJ, Hillen TJ, Zhou G, Schwarz JK, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH. Postradiation damage to the pelvic girdle in cervical cancer patients: is intensity-modulated radiation therapy safer than conventional radiation? International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 806-12. PMID 24670967 DOI: 10.1016/J.Ygyno.2012.07.028 |
0.406 |
|
2014 |
Ioffe YJ, Stewart Massad L, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW. Survival of cervical cancer patients presenting with isolated supraclavicular metastases vs. extra-nodal disease, as assessed by positron-emission tomography (PET) scans Gynecologic Oncology. 135: 407. DOI: 10.1016/J.Ygyno.2014.07.076 |
0.389 |
|
2014 |
Sun B, Deshan Y, Esthappan J, Garcia-Ramirez J, Price S, Mutic S, Schwarz J, Grigsby P, Tanderup K. 3D Dose Accumulation in Pseudo-Split-Field IMRT and BT for Locally Advanced Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S490. DOI: 10.1016/J.Ijrobp.2014.05.1512 |
0.35 |
|
2013 |
Schwarz JK. Translating imaging results into tumor biology: FDG-PET and the response to chemoradiation in human cervical carcinoma. Radiation Research. 180: 223-30. PMID 23899375 DOI: 10.1667/Rr3392.1 |
0.424 |
|
2013 |
Grigsby PW, Zighelboim I, Powell MA, Mutch DG, Schwarz JK. In vitro chemoresponse to cisplatin and outcomes in cervical cancer. Gynecologic Oncology. 130: 188-91. PMID 23583416 DOI: 10.1016/J.Ygyno.2013.04.005 |
0.424 |
|
2013 |
Hu Y, Esthappan J, Mutic S, Richardson S, Gay HA, Schwarz JK, Grigsby PW. Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI. Radiation Oncology (London, England). 8: 16. PMID 23327682 DOI: 10.1186/1748-717X-8-16 |
0.368 |
|
2013 |
Olsen JR, Esthappan J, DeWees T, Narra VR, Dehdashti F, Siegel BA, Schwarz JK, Grigsby PW. Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix. Journal of Magnetic Resonance Imaging : Jmri. 37: 431-4. PMID 23023940 DOI: 10.1002/Jmri.23830 |
0.333 |
|
2012 |
Shokeen M, Zheleznyak A, Wilson JM, Jiang M, Liu R, Ferdani R, Lam KS, Schwarz JK, Anderson CJ. Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 779-86. PMID 22496586 DOI: 10.2967/Jnumed.111.100073 |
0.301 |
|
2012 |
Gaffney D, Mundt A, Schwarz J, Eifel P. Advances in clinical research in gynecologic radiation oncology: an RTOG symposium. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: 667-74. PMID 22398709 DOI: 10.1097/Igc.0B013E31824771Fb |
0.375 |
|
2012 |
Schwarz JK, Lewis JS, Pfeifer J, Huettner P, Grigsby P. Prognostic significance of p16 expression in advanced cervical cancer treated with definitive radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 84: 153-7. PMID 22330994 DOI: 10.1016/J.Ijrobp.2011.11.032 |
0.352 |
|
2012 |
Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW. Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1464-71. PMID 22235101 DOI: 10.1158/1078-0432.Ccr-11-2485 |
0.369 |
|
2012 |
Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 83: 185-90. PMID 22014958 DOI: 10.1016/J.Ijrobp.2011.05.053 |
0.362 |
|
2012 |
Chang AJ, Richardson S, Grigsby PW, Schwarz JK. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 82: 263-9. PMID 21167656 DOI: 10.1016/J.Ijrobp.2010.09.049 |
0.412 |
|
2012 |
Rashmi R, DeSelm C, Schwarz JK. Abstract 2279: Akt inhibitor SC-66 leads to inhibition of mTOR pathway in cervical cancer cell line C33A. Cancer Research. 72: 2279-2279. DOI: 10.1158/1538-7445.Am2012-2279 |
0.346 |
|
2012 |
Dyk P, Apicelli A, Sun B, Bertelsman C, Kavanaugh J, Rolfingsmeier J, DeWees T, Garcia-Ramirez J, Schwarz J, Grigsby P. PO-299 3D MRI-BASED HDR-BRACHYTHERAPY PLANNING AND IMRT FOR THE TREATMENT OF CERVICAL CANCER Radiotherapy and Oncology. 103: S119. DOI: 10.1016/S0167-8140(12)72265-X |
0.365 |
|
2012 |
Dyk P, Apicelli A, Sun B, Bertelsman C, Kavanaugh J, DeWees T, Garcia-Ramirez J, Richardson S, Schwarz J, Grigsby P. Toxicity Following Adaptive MRI Image Guided HDR Brachytherapy and IMRT in the Treatment of Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S443. DOI: 10.1016/J.Ijrobp.2012.07.1173 |
0.388 |
|
2012 |
Apicelli A, Dyk P, Sun B, Bertelsman C, Kavanaugh J, DeWees T, Garcia-Ramirez J, Richardson S, Schwarz J, Grigsby P. Adaptive MRI Image Guided HDR Brachytherapy Treatment Planning for Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S437-S438. DOI: 10.1016/J.Ijrobp.2012.07.1158 |
0.367 |
|
2012 |
Thomas M, El Naqa I, Kidd E, Dehdashti F, Schwarz J, Grigsby P. Intratumoral Heterogeneity Assessed by Extraction of Texture Features from PET Images of Cervical Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 84: S20. DOI: 10.1016/J.Ijrobp.2012.07.055 |
0.374 |
|
2011 |
Schwarz JK, Wahab S, Grigsby PW. Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients. International Journal of Radiation Oncology, Biology, Physics. 81: 1258-63. PMID 20932657 DOI: 10.1016/J.Ijrobp.2010.07.038 |
0.359 |
|
2011 |
Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET. International Journal of Radiation Oncology, Biology, Physics. 81: 772-7. PMID 20888130 DOI: 10.1016/J.Ijrobp.2010.06.008 |
0.303 |
|
2011 |
Hu Y, Mutic S, Esthappan J, Richardson S, Gay H, Schwarz J, Grigsby P. SU-E-J-79: Proton Density Weighted MRI for MR-Guided Radiotherapy for Cervical Cancer Medical Physics. 38: 3460-3460. DOI: 10.1118/1.3611847 |
0.336 |
|
2011 |
Kittel J, Olsen J, Schwarz J, Powell M, Mutch D, Grigsby P. Retrospective Analysis of Clinical Outcomes of Vaginal Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 81: S481. DOI: 10.1016/J.Ijrobp.2011.06.770 |
0.352 |
|
2011 |
Thomas M, Kidd E, Dehdashti F, Schwarz J, Grigsby P. Characterization of the Metabolic Response during Chemoradiation for Cervical Cancer: Early Stratification of Patient Outcome International Journal of Radiation Oncology*Biology*Physics. 81: S188-S189. DOI: 10.1016/J.Ijrobp.2011.06.337 |
0.387 |
|
2011 |
Olsen J, Esthappan J, Hu Y, Schwarz J, Grigsby P. Changes in Tumor Diffusion Measured by DWI during Brachytherapy Correlate with Metabolic Response on FDG-PET and Progression-free Survival for SCC of the Cervix International Journal of Radiation Oncology*Biology*Physics. 81: S188. DOI: 10.1016/J.Ijrobp.2011.06.336 |
0.302 |
|
2011 |
Goddu S, Rodriguez V, Richardson S, Wooten H, Schwarz J, Grigsby P. In Vivo Dose Delivery Verification of Gynecological Cancer IMRT Treatments using TomoTherapy's Exit Detector Data International Journal of Radiation Oncology*Biology*Physics. 81: S815-S816. DOI: 10.1016/J.Ijrobp.2011.06.1435 |
0.337 |
|
2010 |
Hu X, Schwarz JK, Lewis JS, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X. A microRNA expression signature for cervical cancer prognosis. Cancer Research. 70: 1441-8. PMID 20124485 DOI: 10.1158/0008-5472.Can-09-3289 |
0.345 |
|
2009 |
Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, Mutch DG, Grigsby PW, Powell SN, Wang X. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecologic Oncology. 114: 457-64. PMID 19501389 DOI: 10.1016/J.Ygyno.2009.05.022 |
0.364 |
|
2009 |
Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 64S-73S. PMID 19380409 DOI: 10.2967/Jnumed.108.057257 |
0.324 |
|
2009 |
Chang A, Schwarz J, Grigsby P. Prospective Phase I/II Trial of Helical Tomotherapy, Intracavitary Brachytherapy, and Concurrent Chemotherapy in Patients with Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 75: S360. DOI: 10.1016/J.Ijrobp.2009.07.825 |
0.367 |
|
2008 |
Schwarz JK, Lin LL, Siegel BA, Miller TR, Grigsby PW. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 72: 1502-7. PMID 18538498 DOI: 10.1016/J.Ijrobp.2008.03.040 |
0.416 |
|
2008 |
Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. International Journal of Radiation Oncology, Biology, Physics. 71: 180-6. PMID 17996387 DOI: 10.1016/J.Ijrobp.2007.09.005 |
0.371 |
|
2007 |
Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. Jama. 298: 2289-95. PMID 18029833 DOI: 10.1001/Jama.298.19.2289 |
0.369 |
|
2007 |
Grigsby PW, Malyapa RS, Higashikubo R, Schwarz JK, Welch MJ, Huettner PC, Dehdashti F. Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 9: 278-83. PMID 17431727 DOI: 10.1007/S11307-007-0095-2 |
0.302 |
|
2007 |
Schwarz J, Rader J, Huettner P, Watson M, Grigsby P. Molecular Characterization of FDG-PET Metabolic Response in Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 69: S115. DOI: 10.1016/J.Ijrobp.2007.07.213 |
0.374 |
|
2005 |
Lamoreaux WT, Myerson RJ, Malyapa RS, Higashikubo R, Kim E, LaZar MD, Ritter JH, Schwarz J. Predictive Factors for Response of Rectal Cancer to Preoperative Chemoradiotherapy International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.486 |
0.328 |
|
2003 |
Schwarz JK, Lovly CM, Piwnica-Worms H. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Molecular Cancer Research : McR. 1: 598-609. PMID 12805407 |
0.594 |
|
2000 |
Ahn JY, Schwarz JK, Piwnica-Worms H, Canman CE. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Research. 60: 5934-6. PMID 11085506 |
0.482 |
|
2000 |
Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, Piwnica-Worms H. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. The Journal of Biological Chemistry. 275: 5600-5. PMID 10681541 DOI: 10.1074/Jbc.275.8.5600 |
0.526 |
|
1999 |
Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H, Chung JH. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 96: 3745-50. PMID 10097108 DOI: 10.1073/Pnas.96.7.3745 |
0.521 |
|
Show low-probability matches. |